Citation Impact
Citing Papers
The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling
2010
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
2007 Standout
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Bile acid transporters
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Purine nucleoside phosphorylases: properties, functions, and clinical aspects
2000
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
2016
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Crystal Structure of Calf Spleen Purine Nucleoside Phosphorylase with Two Full Trimers in the Asymmetric Unit: Important Implications for the Mechanism of Catalysis
2004 StandoutNobel
Nucleotide signalling during inflammation
2014 StandoutNature
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Extracellular adenosine triphosphate and adenosine in cancer
2010
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Cancer drug resistance: an evolving paradigm
2013 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hepatocyte Polarity
2012
CD73: a potent suppressor of antitumor immune responses
2012
The Bile Acid Tauroursodeoxycholic Acid Modulates Phosphorylation and Translocation of Bad via Phosphatidylinositol 3-Kinase in Glutamate-Induced Apoptosis of Rat Cortical Neurons
2004
Vascular smooth muscle differentiation of murine stroma
1999
The anticancer immune response: indispensable for therapeutic success?
2008
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Mitochondria: In Sickness and in Health
2012 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Lymphangiogenesis in development and human disease
2005 StandoutNature
Insulin Receptor Substrate and p55 Orthologous Adaptor Proteins Function in the Caenorhabditis elegans daf-2/Insulin-like Signaling Pathway
2002 StandoutNobel
Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α
2000
Immunity, Inflammation, and Cancer
2010 Standout
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Membrane lipids: where they are and how they behave
2008 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Akt Signaling Regulates Side Population Cell Phenotype via Bcrp1 Translocation
2003
Microenvironmental regulation of metastasis
2008 Standout
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
2007
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
The PI3K Pathway in Human Disease
2017 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor
2001
Modes of resistance to anti-angiogenic therapy
2008 Standout
Tumor Angiogenesis
2008 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Lipid flippases and their biological functions
2006
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
2001
Adriamycin-induced modulation of host defenses in tumor-bearing mice.
1992
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
2019
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2.
1999
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Ecto‐enzyme and signaling functions of lymphocyte CD 7 3
1998
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
2003
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
2010
Mammalian ABC Transporters in Health and Disease
2002
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Critical nodes in signalling pathways: insights into insulin action
2006 Standout
Genetic and Biochemical Analysis of Non-Vesicular Lipid Traffic
2009
Neural Cell Adhesion Molecule Contributes to Hemopoiesis‐Supporting Capacity of Stromal Cell Lines
2005
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Peter Ujházy being referenced
Doxorubicin plus tumor necrosis factor α combination treatments in EL4-lymphoma-bearing C57BL/6 mice
1998
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation
1998
Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2
1996
Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance
1996
Ecto‐5'‐nucleotidase (CD73) in multidrug‐resistant cell lines generated by doxorubicin
1994
Analysis of the Effect of Intestinal Resection on Rat Ileal Bile Acid Transporter Expression and on Bile Acid and Cholesterol Homeostasis
2002
Familial intrahepatic cholestasis 1: Studies of localization and function
2001
The Role of Phosphoinositide 3-Kinase in Taurocholate-induced Trafficking of ATP-dependent Canalicular Transporters in Rat Liver
1998
Phosphoinositide 3-kinase lipid products regulate ATP-dependent transport by sister of P-glycoprotein and multidrug resistance associated protein 2 in bile canalicular membrane vesicles
1999
The relationship between multidrug resistance and tumor necrosis factor resistance in an EL4 cell line model.
1990
Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
1994
Expression of B cell markers on SR-4987 cells derived from murine bone marrow stroma.
1997
Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.
1993
Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
1990